
Login
Related Links
Advertise on this site?
Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. Click here for more information about advertising.
You can also make a donation by PayPal and support the Gene Therapy Net website.
Companies - M
MaxCyte, Inc. Cell therapeutics company developing cell-based therapies. The company's proprietary, non-viral, ex vivo cell loading technology is used in partnered therapeutic programs in oncology, pulmonary, metabolic and infectious diseases. |
|
MediGene, Inc. MediGene concentrates on commercializing novel drugs in three therapeutic areas: cancer, autoimmune diseases, and skin diseases. |
|
Microbix Biopharmaceutical company specialized in developing biological technologies in the field of biotherapeutics, vaccines and non-therapeutic biologics, including Adeno-associated virus vectors (rAAV) and Adenoviral vectors. |
|
Mirus Corporation Biopharmaceutical company focused on developing innovative nucleic acid based technologies and products. Under development are RNAi gene silencing therapies based on Mirus’ proprietary Dynamic PolyConjugates™ delivery platform. |
|
Molecular Medicine, LLC Company is dedicated to providing a variety of development, manufacturing, and ancillary services for the viral vaccine and viral therapeutic marketplace. |
|
MolMed S.p.A Medical biotechnology company focused on discovery, R&D, and clinical validation of innovative therapies for the treatment of cancer. |
|
Mologen Holding AG Biotechnology company researching and developing innovative DNA-based drugs, inclding improving existing immunological drugs and therapies to combat cancer and developing state-of-the-art vaccines for the prevention and treatment of serious infectious diseases. |
|
Information Companies
Overview of biotechnology companies involved in gene therapy and/or cell therapy, as well as contract research organizations (CRO) and medical supply companies.
The provided information about the companies is just a summary of the information giving on their websites and is therefore not always complete, correct and/or exhaustive. Please visit the companies websites for a complete picture of the company.
Your company not listed? Click here to submit.
Like to work for a company? Find here the perfect job in gene therapy.
Gene Therapy News
- A Positive Outlook on Gene Therapy for Hemophilia B Post-Discontinuation, with Guy Young, MD - HCP Live
Sat, 26 Apr 2025 01:04:1 GMT - Reshaping Retinal Care With Gene Therapy Programs, With Christina Y. Weng, MD - HCP Live
Sat, 26 Apr 2025 01:04:1 GMT - Cell and Gene Therapy Manufacturing Quality Control Market - openPR.com
Fri, 25 Apr 2025 14:21:0 GMT - In a first for St. Louis, patient completes new gene therapy to cure sickle cell disease - STLtoday.com
Fri, 25 Apr 2025 14:20:0 GMT - Cell and Gene Therapy Bioassay Services Market Focusing On - openPR.com
Fri, 25 Apr 2025 14:15:0 GMT - U.K. Cell and Gene Therapy Research Challenges Market Projected - openPR.com
Fri, 25 Apr 2025 10:50:0 GMT - Gene Therapy Shows Long-Term Benefits in Pediatric Neuron Disease - MedPage Today
Thu, 24 Apr 2025 23:15:1 GMT - Scientists achieve breakthrough in gene therapy for haemophilia - Times of India
Thu, 24 Apr 2025 20:46:0 GMT - Tenaya reports progress in ARVC gene therapy study - Investing.com
Thu, 24 Apr 2025 20:29:5 GMT - Major Breakthrough: 175-Patient ARVC Study Shows 93% Could Benefit from New Gene Therapy Treatment - Stock Titan
Thu, 24 Apr 2025 20:07:0 GMT - Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene Therapy - Genetic Engineering and Biotechnology News
Thu, 24 Apr 2025 18:39:2 GMT - Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa - Business Wire
Thu, 24 Apr 2025 18:26:0 GMT - Gene therapy delivered early can help children with rare neurodegenerative disease retain motor and cognitive functions - Medical Xpress
Thu, 24 Apr 2025 18:14:0 GMT - Hemophilia Gene Therapy Market Is Booming Worldwide 2025-2032 | - openPR.com
Thu, 24 Apr 2025 16:37:0 GMT - Cell And Gene Therapy Market Set to Witness Significant Growth by 2025-2032 | Novartis International AG, Pfizer, Inc. - openPR.com
Thu, 24 Apr 2025 16:30:0 GMT